Tag: Liver
Laparoscopic Resection May Be An Option for CRC Liver Metastases
For resectable colorectal liver metastases, five-year survival rates similar with laparoscopic, open surgery
Rurality, Income Impact Stage at Diagnosis, Mortality in Liver Cancer
Patients from rural regions, lower-income households have more advanced stage at diagnosis of HCC
Viral Exposure Signature Predicts Hepatocellular Carcinoma
Signature can identify hepatocellular carcinoma patients before clinical diagnosis
Atezolizumab-Bevacizumab Beats Sorafenib in Liver Cancer
Overall, progression-free survival longer with combo in unresectable hepatocellular carcinoma
1990 to 2017 Saw Increases in Primary Liver Cancer Cases
PLC cases diagnosed before age 30 decreased, but those diagnosed at 30 to 59, ≥60 years increased
Risk for Liver Cancer Down With Low-Dose Aspirin in Hepatitis B, C
Risk for 10-year liver-related mortality also lower among aspirin users with chronic hepatitis B or C
QoL Extended With Atezolizumab + Bevacizumab in Liver Cancer
And, triplet and doublet drug regimens delay decline in quality of life in BRAF V600E metastatic CRC
Patients With Cirrhosis Have Considerable Financial Burden
Lack of insurance, financial distress resulting in delayed medical care tied to lower odds of HCC surveillance
Lipophilic Statins May Cut Liver Cancer in Chronic Viral Hepatitis
Inverse link is dose-dependent; lowest 10-year HCC risk seen with 600 or more lipophilic statin cDDDs
DAAs Cut Deaths in Those Treated for HCV-Related Liver Cancer
Findings seen for patients receiving direct-acting antivirals with complete response to liver cancer treatment
